BioAtla Reports Fourth Quarter and Full Year 2022 Financial
- Cleared dose-limiting toxicity (DLT) observation period with more frequent, dose-intensive regimen of CAB-AXL BA3011; anticipated leiomyosarcoma (LMS)...
Source: globenewswire.com
Page 2 - Conditionally Active Biologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Conditionally Active Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Conditionally Active Biologic Today - Breaking & Trending Today
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
- Cleared dose-limiting toxicity observation period with more frequent, dose-intensive regimen of CAB-AXL BA3011; anticipated leiomyosarcoma cohort readout in 2H23 - Initiated the potentially... | March 23, 2023
Source: marketscreener.com
BioAtla Announces Change in Executive Leadership
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of...
Source: globenewswire.com
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Scott A. Smith and Elisha W. Finney have been appointed as...
Source: prnewswire.com
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Scott A. Smith and Elisha W. Finney have been appointed as...
Source: prnewswire.com